Skip to main content
. 2016 Aug 12;7(36):58174–58180. doi: 10.18632/oncotarget.11272

Table 3. Genotype frequencies of mTOR rs2295080 polymorphism in breast cancers and controls.

Model Genotype Case (n, %) Control (n, %) OR (95% CI) P-value
Codominant T/T 351 (62.7%) 345 (59.2%) 1.00
G/T 197 (35.2%) 212 (36.4%) 0.91 (0.72–1.17)
G/G 12 (2.1%) 26 (4.4%) 0.45 (0.23–0.91) 0.02
Dominant T/T 351 (62.7%) 345 (59.2%) 1.00
G/T–G/G 209 (37.3%) 238 (40.8%) 0.86 (0.68–1.09) 0.23
Recessive T/T–G/T 548 (97.9%) 557 (95.9%) 1.00
G/G 12 (2.1%) 26 (4.4%) 0.47 (0.23–0.94) 0.03
Overdominant T/T–G/G 363 (64.8%) 371 (63.6%) 1.00
G/T 197 (35.2%) 212 (36.4%) 0.95 (0.75–1.21) 0.68
Allele T 899(80.3%) 902 (77.4%) 1.00
G 221(19.7%) 264 (22.6%) 0.84 (0.69–1.03) 0.04